Risk of breast cancer in relation to antibiotic use

Pharmacoepidemiology and Drug Safety

Volumn 17, Issue 2, 2008, Pages 144-150

  Tamim, Hani M ^a,b,f   Hanley, James A ^c   Hajeer, Ali H ^b   Boivin, Jean François ^c,d   Collet, Jean Paul ^e  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^c Lady Davis Institute for Medical Research ^*  (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

Anti bacterial agents; Antibiotics; Breast cancer; Breast neoplasms; Case control study

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN G; SULFONAMIDE; TETRACYCLINE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANADA; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CHILD; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; DATABASES, FACTUAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INCIDENCE; RISK ASSESSMENT; RISK FACTORS; SASKATCHEWAN; TIME FACTORS;

EID: 39749179106     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1512     Document Type: Article

References (23)

1. Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH. Antibiotic use in relation to the risk of breast cancer. JAMA 2004; 291(7): 827-835.
2. Didham RC, Reith DM, McConnell DW, Harrison KS. Antibiotic exposure and breast cancer in New Zealand. Breast Cancer Res Treat 2005; 92(2): 163-167.
3. Friedman GD, Oestreicher N, Chan J, Quesenberry CP, Jr. Udaltsova N, Habel LA. Antibiotics and risk of breast cancer: up to 9 years of follow-up of 2.1 million women. Cancer Epidemiol Biomarkers Prev 2006; 15(11): 2102-2106.
4. Garcia Rodriguez LA, Gonzalez-Perez A. Use of antibiotics and risk of breast cancer. Am J Epidemiol 2005; 161(7): 616-619.
5. Kaye JA, Jick H. Antibiotics and the risk of breast cancer. Epidemiology 2005; 16(5): 688-690.
6. Sorensen HT, Skriver MV, Friis S, McLaughlin JK, Blot WJ, Baron JA. Use of antibiotics and risk of breast cancer: a population-based case-control study. Br J Cancer 2005; 92(3): 594-596.
7. Tamim H, Boivin JF, Hanley J, Stang M, Collet JP. Risk of breast cancer in association with exposure to two different groups of tricyclic antidepressants. Pharmacoepidemiol Drug Saf 2006; 15(10): 689-697.
8. Xu W, Tamim H, Shapiro S, Stang MR, Collet JP. Use of antidepressants and risk of colorectal cancer: a nested case-control study. Lancet Oncol 2006; 7(4): 301-308.
9. Downey W. Health databases in Saskatchewan. In Pharmacoepidemiology, Strom B (ed.) (3rd edn). John Wiley and Sons, Ltd.: Chichester, 2000; 325-345.
10. Percy C, Van Molten V, Muir C. International Classification of Diseases for Oncology (ICD-O) (2nd edn). World Health Organization: Geneva, Switzerland; 1990.
11. Mandell G, Douglas R, Bennett J, Dolin R Mandell. Douglas, and Bennett's Principles and Practice of Infectious Diseases (4th edn). Livingstone: Philadelphia Churchill; 2000.
12. Miettinen O. Theoretical Epidemiology: Principles of Occurrence Research in Medicine. Delmar Publishers: Albany (NY); 1985.
13. SAS Institute Inc. The SAS system for windows software, release 8: SAS Institute Inc: NC; 1999.
14. Knekt P, Adlercreutz H, Rissanen H, Aromaa A, Teppo L, Heliovaara M. Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer? Br J Cancer 2000; 82(5): 1107-1110.
15. Ishii A, Matsuoka H, Aji T, et al. Parasite infection and cancer: with special emphasis on Schistosoma japonicum infections (Trematoda). A review. Mutat Res 1994; 305(2): 273-281.
16. Harris RE, Chlebowski RT, Jackson RD. et al. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res 2003; 63(18): 6096-6101.
17. Collet JP, Sharpe C, Belzile E, Boivin JF, Hanley J, Abenhaim L. Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing. Br J Cancer 1999; 81(1): 62-68.
18. Sharpe CR, Collet JP, McNutt M, Belzile E, Boivin JF, Hanley JA. Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage. Br J Cancer 2000; 83(1): 112-120.
19. Reed MJ, Purohit A. Breast cancer and the role of cytokines in regulating estrogen synthesis: an emerging hypothesis. Endocr Rev 1997; 18(5): 701-715.
20. Williams L, Jenkins GJ, Doak SH, et al. Fluorescence in situ hybridisation analysis of chromosomal aberrations in gastric tissue: the potential involvement of Helicobacter pylori. Br J Cancer 2005; 92(9): 1759-1766.
21. Ye W, Held M, Lagergren J, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 2004; 96(5): 388-396.
22. Badawi AF, Mostafa MH, Probert A, O'Connor PJ. Role of schistosomiasis in human bladder cancer: evidence of association, aetiological factors, and basic mechanisms of carcinogenesis. Eur J Cancer Prev 1995; 4(1): 45-59.
23. Monson RR, Yen S, MacMahon B. Chronic mastitis and carcinoma of the breast. Lancet 1976; 2(7979): 224-226.